L233-0954 Screening compound: 2-[4-({5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine

L233-0954 Screening compound: 2-[4-({5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine
L233-0954 Screening compound: 2-[4-({5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L233-0954
2-[4-({5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L233-0954

Molecular Formula

C21H19FN6O3S2 (C21 H19 FN6 O3 S2)

Compound Name

2-[4-({5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine

IUPAC name

2-[4-({5-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]-2-methylthiophen-3-yl}sulfonyl)piperazin-1-yl]pyrimidine

SMILES

Cc(sc(-c1nc(-c(cc2)ccc2F)no1)c1)c1S(N(CC1)CCN1c1ncccn1)(=O)=O

InChI

InChI=1S/C21H19FN6O3S2/c1-14-18(33(29,30)28-11-9-27(10-12-28)21-23-7-2-8-24-21)13-17(32-14)20-25-19(26-31-20)15-3-5-16(22)6-4-15/h2-8,13H,9-12H2,1H3

InChI Key

JGZHYUGCFGPYIC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27237324

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.55

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.490

Distribution Coefficient, logD

4.490

Water Solubility, LogSw

-4.30

Polar Surface Area

85.996

Acid Dissociation Constant (pKa)

20.87

Base Dissociation Constant (pKb)

3.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

L233-0954 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L233-0954 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L233-0954?
Check Price and Availability of L233-0954, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L233-0954 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L233-0954
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L233-0954
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L233-0954 available by request